BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22617059)

  • 21. "MRI Stealth" robot for prostate interventions.
    Stoianovici D; Song D; Petrisor D; Ursu D; Mazilu D; Muntener M; Schar M; Patriciu A
    Minim Invasive Ther Allied Technol; 2007; 16(4):241-8. PubMed ID: 17763098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR-guided biopsy of the prostate: an overview of techniques and a systematic review.
    Pondman KM; Fütterer JJ; ten Haken B; Schultze Kool LJ; Witjes JA; Hambrock T; Macura KJ; Barentsz JO
    Eur Urol; 2008 Sep; 54(3):517-27. PubMed ID: 18571309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiparametric MRI for prostate cancer screening].
    Hoeks CM; Fütterer JJ; Somford DM; van Oort IM; Huisman H; Barentsz JO
    Ned Tijdschr Geneeskd; 2009; 153():B487. PubMed ID: 20003566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applications.
    Yakar D; Hambrock T; Hoeks C; Barentsz JO; Fütterer JJ
    Top Magn Reson Imaging; 2008 Dec; 19(6):291-5. PubMed ID: 19512851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-Guided percutaneous biopsy of breast lesions: materials, techniques, success rates, and management in patients with suspected radiologic-pathologic mismatch.
    Floery D; Helbich TH
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):411-25, viii. PubMed ID: 17098182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial comment on: MR-guided biopsy of the prostate: an overview of techniques and a systematic review.
    Coleman JA
    Eur Urol; 2008 Sep; 54(3):525-6. PubMed ID: 18571310
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial comment on: MR-guided biopsy of the prostate: an overview of techniques and a systematic review.
    Sciarra A
    Eur Urol; 2008 Sep; 54(3):526-7. PubMed ID: 18571308
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraprostatic targeting.
    Ukimura O; Faber K; Gill IS
    Curr Opin Urol; 2012 Mar; 22(2):97-103. PubMed ID: 22249373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates.
    Tilak G; Tuncali K; Song SE; Tokuda J; Olubiyi O; Fennessy F; Fedorov A; Penzkofer T; Tempany C; Hata N
    J Magn Reson Imaging; 2015 Jul; 42(1):63-71. PubMed ID: 25263213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
    Lawrentschuk N; Fleshner N
    BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The case for MR-compatible robotics: a review of the state of the art.
    Elhawary H; Tse ZT; Hamed A; Rea M; Davies BL; Lamperth MU
    Int J Med Robot; 2008 Jun; 4(2):105-13. PubMed ID: 18481822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging compatible robotic system for fully automated brachytherapy seed placement.
    Muntener M; Patriciu A; Petrisor D; Mazilu D; Bagga H; Kavoussi L; Cleary K; Stoianovici D
    Urology; 2006 Dec; 68(6):1313-7. PubMed ID: 17169653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-Bore MR-Guided Biopsy Systems and Utility of PI-RADS.
    Fütterer JJ; Moche M; Busse H; Yakar D
    Top Magn Reson Imaging; 2016 Jun; 25(3):119-23. PubMed ID: 27187168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robot-assisted needle placement in open-MRI: system architecture, integration and validation.
    DiMaio SP; Pieper S; Chinzei K; Hata N; Balogh E; Fichtinger G; Tempany CM; Kikinis R
    Stud Health Technol Inform; 2006; 119():126-31. PubMed ID: 16404030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR-guided interventions for prostate cancer.
    Atalar E; Ménard C
    Magn Reson Imaging Clin N Am; 2005 Aug; 13(3):491-504. PubMed ID: 16084415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
    Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
    Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels.
    Lichy MP; Anastasiadis AG; Aschoff P; Sotlar K; Eschmann SM; Pfannenberg C; Stenzl A; Claussen CD; Schlemmer HP
    Urology; 2007 Jun; 69(6):1208.e5-8. PubMed ID: 17572221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
    Kapustin VV
    Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.